U-4113

TREATMENT OF TREATMENT RESISTANT DEPRESSION IN ADULTS BY NASALLY ADMINISTERING 56MG OR 84MG 2X WEEKLY FOR 4 WEEKS DURING THE INDUCTION PHASE